Capital Fund Management S.A. Takeda Pharmaceutical CO LTD Transaction History

Capital Fund Management S.A.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.89 - $15.04 $360,028 - $389,836	-25,920 Reduced 27.3%	69,026 $958,000
Q4 2023 Feb 14, 2024	BUY	$13.36 - $15.43 $1.27 Million - $1.47 Million	94,946 New	94,946 $1.35 Million
Q2 2022 Aug 12, 2022	BUY	$13.12 - $15.03 $492,747 - $564,481	37,557 Added 131.39%	66,141 $928,000
Q1 2022 May 12, 2022	BUY	$13.54 - $15.35 $60,672 - $68,783	4,481 Added 18.59%	28,584 $409,000
Q4 2021 Feb 10, 2022	BUY	$13.17 - $16.4 $317,436 - $395,289	24,103 New	24,103 $328,000
Q1 2020 May 13, 2020	SELL	$13.02 - $20.31 $1.18 Million - $1.84 Million	-90,513 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$16.88 - $20.83 $5,215 - $6,436	-309 Reduced 0.34%	90,513 $1.79 Million
Q3 2019 Nov 13, 2019	SELL	$16.15 - $17.99 $44,493 - $49,562	-2,755 Reduced 2.94%	90,822 $1.56 Million
Q2 2019 Aug 12, 2019	SELL	$16.58 - $20.49 $51,878 - $64,113	-3,129 Reduced 3.24%	93,577 $1.66 Million
Q1 2019 May 13, 2019	BUY	$16.7 - $21.52 $1.61 Million - $2.08 Million	96,706 New	96,706 $1.97 Million

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.